Stay updated on Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial
Sign up to get notified when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.

Latest updates to the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedFooter now includes 'Revision: v3.3.3'. The 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' references were removed.SummaryDifference0.1%

- Check46 days agoChange DetectedA minor version update was applied: Revision: v3.3.2 was added and Revision: v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check53 days agoChange DetectedThe page revision is updated to v3.3.1, replacing the previous v3.2.0.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved a government funding/operating status notice from the page; the core trial information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check74 days agoChange DetectedThe new screenshot shows a layout change (header/navigation/spacing) with no changes to the actual study details or criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.